Intelligence Platform

Patents

Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 7320991

Analogs of thalidomide as potential angiogenesis inhibitors

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314885

Pyrrole compounds useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7312227

Compositions useful as inhibitors of JAK and other protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7312226

Substituted tricyclic compounds as protein kinase inhibitors

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7306799

Use of VEGF inhibitors for treatment of eye disorders

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7304071

Protein kinase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7304061

Heterocyclic inhibitors of ERK2 and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7303747

Use of VEGF inhibitors for treatment of eye disorders

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7288624

Inhibitors of interleukin-1β converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7285556

Thienopyrimidine-based inhibitors of the src family

The Board of Regents of the University of Texas System · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7279476

Pyrazole-derived kinase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7279469

Diaminotriazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7276502

Thiazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7276348

Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7273851

Tri-peptide hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7273885

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7271186

Nanomolar β-lactamase inhibitors

Northwestern University · Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7271181

Inhibitors of p38

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7271179

Inhibitors of JAK protein kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7268122

Use of oversulfated polysaccharides as inhibitors of HIV

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7268136

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7259161

Compositions useful as inhibitors of JAK and other protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7259142

Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256171

Use of core 2 G1cNAc transferase inhibitors in treating inflammation

The Regents of the University of California · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)